Geneva, Switzerland and Boston, MA – October 22, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s ...
Geneva, Switzerland and Boston, MA – October 20, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals (US) today announced that it will present eleven company-sponsored abstracts, including six oral presentations, at the American Society for ...
OLD SAYBROOK, Conn. and WARWICK, United Kingdom, Oct. 20, 2020 /PRNewswire/ -- Fertility Focus, the manufacturers of OvuSense – a leading fertility monitor with class II medical device classification ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results